The schizophrenic faces of PICK1

Trends Pharmacol Sci. 2006 Nov;27(11):574-9. doi: 10.1016/j.tips.2006.09.007. Epub 2006 Sep 29.

Abstract

Schizophrenia is a grave psychiatric disorder with psychotic symptoms and an enigmatic etiology. Family studies have strongly indicated that genetic risk factors have a role in this disease. Recent findings, together with previously established evidence, highlight the PDZ-domain-containing protein interacting with C-kinase 1 (PICK1) as a promising candidate for a schizophrenia susceptibility gene. Here, we outline possible molecular mechanisms, discuss clinical case-studies that indicate an unexpected role of PICK1 in schizophrenia and discuss potential avenues for pharmacological manipulation of PICK1.

Publication types

  • Review

MeSH terms

  • Animals
  • Antipsychotic Agents / pharmacology
  • Carrier Proteins / antagonists & inhibitors
  • Carrier Proteins / chemistry
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Genetic Predisposition to Disease
  • Humans
  • Nuclear Proteins / antagonists & inhibitors
  • Nuclear Proteins / chemistry
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism*
  • Polymorphism, Single Nucleotide
  • Protein Kinase C-alpha / metabolism
  • Protein Structure, Tertiary
  • Racemases and Epimerases / metabolism
  • Receptors, Glutamate / metabolism
  • Schizophrenia / genetics
  • Schizophrenia / metabolism*
  • Signal Transduction*

Substances

  • Antipsychotic Agents
  • Carrier Proteins
  • Dopamine Plasma Membrane Transport Proteins
  • Nuclear Proteins
  • PICk1 protein, human
  • Receptors, Glutamate
  • PRKCA protein, human
  • Protein Kinase C-alpha
  • Racemases and Epimerases
  • serine racemase